Weikun Qu, MD, Associate Professor and master’s supervisor, is a Deputy Chief Physician in the Department of Hepatobiliary Surgery and a member of the Communist Party of China. He currently serves as Director of the Organ Procurement Organization (OPO) Office at the Second Affiliated Hospital of Dalian Medical University, and concurrently holds management roles in the Organ Donation Administration Office and the Regional Healthcare Development Department. He has long been engaged in the clinical administration, discipline development, and capacity building related to organ donation coordination and transplantation.
His academic appointments include Member of the Donation and Procurement Group, Organ Transplantation Branch of the Chinese Medical Association; Member of the Organ Donation and Transplantation Professional Committee, Chinese Hospital Association; and Standing Committee Member of the Organ Transplantation Branch, Liaoning Medical Association, among others.
In research, Dr. Qu adheres to a clinically driven approach supported by mechanistic studies to facilitate translational application. Since 2013, he has continuously conducted basic and translational research on hepatobiliary and renal diseases, emphasizing clinically relevant scientific questions and aiming to translate mechanistic discoveries into practical diagnostic and therapeutic strategies. In 2017, he obtained the National Qualification Certificate for Organ Donation Coordinators. His current research focuses on hepatorenal injury and repair and the associated systemic inflammatory responses, spanning organ transplantation, inflammation and immunity, oncology, and translational medicine. In recent years, he has published multiple SCI-indexed papers in related fields and obtained several patents.
He has led one provincial-level project, one Dalian municipal project, and one industry-sponsored project, and has participated in one National Natural Science Foundation of China (NSFC) project, one provincial-level project (second contributor), and one Joint Fund project of the Collaborative Innovation Center for Personalized Diagnosis and Treatment (second contributor). He has published 8 SCI papers and has been granted 2 invention patents.